Notice of Participation in the Luncheon Seminar at the 4th Annual Meeting of the Japanese Society for Antibody Research
"Next-Generation CHO Cell Line Development Service Integrating AI and Process Intensification - Innovation of Sartorius CLD Workflow"
In biopharmaceutical development, establishing high-quality cell lines in a short period has become increasingly important. Sartorius's Cell Line Development (CLD) service has supported the approval of 7 antibody products and over 80 clinical projects to date.
Seminar Points:
■ The latest workflow that selects optimal clones by AI analysis of nano-well images and fluorescence data immediately after single-cell cloning with CellCelector
■ A series of CLD processes that continue from Clone Evaluation, quality analysis, scale-up, to technology transfer to CDMO
■ Process Intensification strategies based on High Inoculation Fed-Batch and Perfusion culture
■ Media optimization service that can be used independently (supporting non-GMP prototypes to GMP manufacturing scale)
Date and Time: December 3 (Wednesday) 12:20–13:20
Venue: Omiya Sonic City, Exhibition Hall 2

| Date and time | Wednesday, Dec 03, 2025 12:20 PM ~ 01:20 PM |
|---|---|
| Capital | Omiya Sonic City, 1-7-5 Sakuragi-cho, Omiya-ku, Saitama-shi, Saitama 330-8669, Sonic City Building |
| Entry fee | Free Participation in the academic conference requires a fee, but there is no additional cost for attending the seminar. |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration






